ID: ALA5094741

Max Phase: Preclinical

Molecular Formula: C22H18ClF3N4O3

Molecular Weight: 478.86

Molecule Type: Unknown

Representations

Canonical SMILES:  O=C(Nc1ccc(NCc2ccc(C(=O)NO)cc2)cc1)Nc1ccc(Cl)c(C(F)(F)F)c1

Standard InChI:  InChI=1S/C22H18ClF3N4O3/c23-19-10-9-17(11-18(19)22(24,25)26)29-21(32)28-16-7-5-15(6-8-16)27-12-13-1-3-14(4-2-13)20(31)30-33/h1-11,27,33H,12H2,(H,30,31)(H2,28,29,32)

Standard InChI Key:  HXPSABUEVHQNFN-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 478.86

Molecular Weight (Monoisotopic): 478.1020

AlogP: 5.73

#Rotatable Bonds: 6

Polar Surface Area: 102.49

Molecular Species: NEUTRAL

HBA: 4

HBD: 5

#RO5 Violations: 1

HBA (Lipinski): 7

HBD (Lipinski): 5

#RO5 Violations (Lipinski): 1

CX Acidic pKa: 9.05

CX Basic pKa: 3.76

CX LogP: 4.65

CX LogD: 4.64

Aromatic Rings: 3

Heavy Atoms: 33

QED Weighted: 0.23

Np Likeness Score: -1.44

References

1. Lee S, Wang SW, Yu CL, Tai HC, Yen JY, Tuan YL, Wang HH, Liu YT, Chen SS, Lee HY..  (2021)  Effect of phenylurea hydroxamic acids on histone deacetylase and VEGFR-2.,  50  [PMID:34634618] [10.1016/j.bmc.2021.116454]

Source

Source(1):

• Scientific Literature